Insights

Medibank (ASX:MPL) dividend boost as payout ratio reduced

The company has bumped up its dividend to shareholders…
The post Medibank (ASX:MPL) dividend boost as payout ratio reduced appeared first on The Motley Fool Australia. –

The Medibank Private Ltd (ASX: MPL) dividend received a boost following the company’s FY21 full-year results today.

However, not all was rosy as management decided to reduce the dividend payout ratio. This comes despite the company achieving a bigger net profit after tax (NPAT) over the period.

Let’s take a look at how Medibank performed for the period and when it will pay its upcoming dividend.

How did Medibank perform in FY21?

The private health insurer delivered outstanding growth for the 12 months ending 30 June 2021.

The group recorded total revenue of $6.9 billion, up 1.99% over the prior corresponding period (pcp). This was underpinned by strong net resident policyholders, up 82,500 including 29,600 for the Medibank brand.

In addition, NPAT surged to $441.2 million, a jump of 39.8% regardless of operating expenses lifting 1.12% compared to FY20. The bottom-line result was aided by net investment income of $120 million, up from $2.4 million this time last year.

In light of the robust performance, the Medibank board decided to bump up its fully-franked full-year dividend to 12.7 cents per share. This makes up a final dividend of 6.9 cents, up 9.5% from FY20.

Medibank also noted that the total ordinary dividend represents a payout ratio of 87.7% of underlying NPAT. While in range of its target payout ratio range of 75% to 85%, this is lower than the 90.1% given to shareholders in FY20.

Based on the current Medibank share price of $3.55 apiece, this gives the company a trailing dividend yield of just over 3.57%.

Medibank dividend key dates

Medibank released the distribution amount and payment dates of its final dividend for the 2021 financial year. Here’s a summary of the important dates Medibank shareholders will need to know for the next month.

Ex-dividend date

The ex-dividend date will be 8 September 2021.

Traditionally, one day before the record date, the ex-dividend date is when investors must have purchased Medibank shares. If the investor does not buy Medibank shares before this date, the dividend will go to the seller.

Record date

The record date for Medibank’s final dividend is 9 September 2021.

This is the date where the company identifies which investors are on its books. Those who are on Medibank’s register will be eligible to receive its upcoming dividend.

Payment date

The payment date for Medibank’s dividend will be 30 September 2021.

This is when investors can expect to see the final dividend of 6.9 cents per share hit their accounts.

The post Medibank (ASX:MPL) dividend boost as payout ratio reduced appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank right now?

Before you consider Medibank, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Medibank (ASX:MPL) share price on watch after 40% jump in profit
How did the Medibank (ASX:MPL) share price respond last earnings season?
10 ASX shares we’re overweight in right now: fund

The Medibank (ASX:MPL) share price is up 18% so far in 2021. Here’s why
3 ASX 200 dividend shares lifting to 52-week highs

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!